Blog

IFF Names New President of Nourish and Introduces Leadership Structure Aligned to New Operating Model

Yuvraj Arora, currently President, U.S. Categories for Kellogg North America, brings 25+ years of multinational CPG experience to IFF’s Executive Leadership TeamNEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) today announced that Yuvraj Arora, currently President, U.S. Categories for Kellogg North America, will join IFF as President, Nourish, effective June 19, 2023. Arora…
Leer más...

AlTi Global, Inc. Announces Completion of Exchange Offer and Consent Solicitation and Notice of Exercise Right to Mandatorily Exchange Remaining Outstanding Warrants

NEW YORK--(BUSINESS WIRE)--AlTi Global, Inc. (“AlTi,” "we" or the "company") (NASDAQ: ALTI), a leading independent global wealth and asset manager, today announced the completion of its previously announced exchange offer (the “Offer”) and consent solicitation (the “Consent Solicitation”) relating to its outstanding warrants, consisting of: (i) the warrants sold as…
Leer más...

Utz Brands, Inc. to Webcast Presentation at the Oppenheimer 23rd Annual Consumer Growth and E-Commerce Virtual Conference on June 13

HANOVER, Pa.--(BUSINESS WIRE)--Utz Brands, Inc. (NYSE: UTZ) (“Utz” or the “Company”), a leading U.S. manufacturer of branded salty snacks, plans to present at the Oppenheimer 23rd Annual Consumer Growth and E-Commerce Virtual Conference on Tuesday, June 13, 2023, at 10:30 a.m. ET. The live webcast can be accessed at the…
Leer más...

Smartsheet Inc. Announces First Quarter Fiscal Year 2024 Results

First quarter total revenue grew 31% year over year to $219.9 million First quarter operating cash flow of $34.6 million and free cash flow of $31.3 million Ended the quarter with cash, cash equivalents, and short-term investments of $489.5 million BELLEVUE, Wash.--(BUSINESS WIRE)--$SMAR #earnings--Smartsheet Inc. (NYSE: SMAR), the enterprise platform…
Leer más...

Repare Therapeutics Reports Proof of Concept for Lunresertib (RP-6306) in Clinic, Initial Monotherapy Data from Phase 1 MYTHIC Clinical Trial and Early Insights from Ongoing Combination Trials

Findings from the ongoing Phase 1 MYTHIC study demonstrated a favorable and distinctive tolerability profile for monotherapy lunresertib Monotherapy antitumor activity observed, including confirmed partial response and several patients with long stable disease Identified both intermittent and continuous schedules to enable combination studies Encouraging early responses across gemcitabine, camonsertib and…
Leer más...

Torrid Reports First Quarter Fiscal 2023 Results

Delivered First Quarter Adjusted EBITDA(1) in line with Guidance Updates Full Year Fiscal 2023 Guidance CITY OF INDUSTRY, Calif.--(BUSINESS WIRE)--Torrid Holdings Inc. (“Torrid” or the “Company”) (NYSE: CURV), a direct-to-consumer apparel, intimates, and accessories brand in North America for women sizes 10 to 30, today announced its financial results for…
Leer más...

GameStop Announces Election of Ryan Cohen as Executive Chairman

GRAPEVINE, Texas--(BUSINESS WIRE)--GameStop Corp. (NYSE: GME) (“GameStop” or the “Company”) today disclosed that its Board of Directors has elected Ryan Cohen as Executive Chairman, effective immediately. Mr. Cohen’s responsibilities include capital allocation and overseeing management. In conjunction, the Company’s former CEO has been terminated. Contacts GameStop Corp. Investor Relations (817)…
Leer más...